THURSDAY, April 2, 2026 — Folks with severe plaque psoriasis often have to choose between convenient pills that don’t work very well or...

Living with diabetes often means dealing with daily insulin injections. For many people, this routine is not only uncomfortable but also emotionally...

Highlights: First once-daily oral peptide approved as a first-line systemic treatment for plaque psoriasis Clini

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A...

Business Wire India About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque...

TUESDAY, March 24, 2026 -- The U.S. Food and Drug Administration has approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist,...

New oral psoriasis treatment Icotyde shows superior results over injectables, delivering clear skin with a safe, once-daily dose for eligible...

FRIDAY, April 3, 2026 — Even though most folks know it's key to good health, sleep often goes undiscussed during doctor visits, a new survey...

FRIDAY, April 3, 2026 — Even though most folks know it's key to good health, sleep often goes undiscussed during doctor visits, a new survey...

OSAKA, Japan and CAMBRIDGE, Massachusetts, March 28, 2026 – Takeda (TSE:4502/NYSE:TAK) today announced new data from the two pivotal Phase 3...